We have located links that may give you full text access.
JOURNAL ARTICLE
RANDOMIZED CONTROLLED TRIAL
Does kinesiotaping increase the efficacy of lidocaine injection in myofascial pain syndrome treatment? A randomized controlled study.
BACKGROUND: Myofascial pain syndrome is a common form of musculoskeletal disorder that originates from a painful site in a muscle or related fascia. There are various non-invasive and invasive treatment methods.
OBJECTIVE: To investigate the efficacy of myofascial trigger point kinesiotaping with that of local anesthetic injection alone on the degree of pain and quality of life in myofascial pain syndrome.
METHODS: Seventy-six patients with myofascial pain syndrome were randomly assigned to three study groups. Group 1 (n= 26) received only local anesthetic (1 ml lidocaine of 0.5% for each trigger point) injection. Group 2 (n= 25) received local anesthetic injection + sham kinesiotaping. Group 3 (n= 25) received local anesthetic injection + kinesiotaping. Pain intensity was measured by visual analog scale (VAS) at baseline, immediately after treatment, and in the 1st and 4th week post-treatment. To evaluate the effect of treatment on quality of life, Short Form-12 (SF-12) was used at baseline and at 4th week post-treatment.
RESULTS: Group 3 showed significantly more improvement than other groups at post-treatment VAS, SF-12 physical component evaluations (p< 0.05). No significant difference was found between groups 2 and 3 in the mental component of SF-12 (p> 0.05), but the patients in group 3 performed significantly better than group 1 (p< 0.05). No significant difference was found between groups 1 and 2 in VAS, SF12 Physical Components Summary and SF-12 Mental Components Summary scores at post-treatment evaluations.
CONCLUSION: This study indicated that kinesiotaping may be useful to increase the efficacy of myofascial trigger point lidocaine injection in myofascial pain syndrome.
OBJECTIVE: To investigate the efficacy of myofascial trigger point kinesiotaping with that of local anesthetic injection alone on the degree of pain and quality of life in myofascial pain syndrome.
METHODS: Seventy-six patients with myofascial pain syndrome were randomly assigned to three study groups. Group 1 (n= 26) received only local anesthetic (1 ml lidocaine of 0.5% for each trigger point) injection. Group 2 (n= 25) received local anesthetic injection + sham kinesiotaping. Group 3 (n= 25) received local anesthetic injection + kinesiotaping. Pain intensity was measured by visual analog scale (VAS) at baseline, immediately after treatment, and in the 1st and 4th week post-treatment. To evaluate the effect of treatment on quality of life, Short Form-12 (SF-12) was used at baseline and at 4th week post-treatment.
RESULTS: Group 3 showed significantly more improvement than other groups at post-treatment VAS, SF-12 physical component evaluations (p< 0.05). No significant difference was found between groups 2 and 3 in the mental component of SF-12 (p> 0.05), but the patients in group 3 performed significantly better than group 1 (p< 0.05). No significant difference was found between groups 1 and 2 in VAS, SF12 Physical Components Summary and SF-12 Mental Components Summary scores at post-treatment evaluations.
CONCLUSION: This study indicated that kinesiotaping may be useful to increase the efficacy of myofascial trigger point lidocaine injection in myofascial pain syndrome.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app